Luteinizing hormone acts at the hippocampus to dampen spatial memory

Hormones and Behavior

Volumn 89, Issue , 2017, Pages 55-63

  Burnham, Veronica ^a   Sundby, Christopher ^a   Laman Maharg, Abigail ^a   Thornton, Janice ^a  

^a OBERLIN COLLEGE   (United States)

Author keywords

Aging; Alzheimer's disease; Estrogen; Hippocampus; Luteinizing hormone; Spatial memory

Indexed keywords

CHORIONIC GONADOTROPIN; DEGLYCOCHORIONIC GONADOTROPIN; ESTRADIOL; ITURELIX; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; HORMONE ANTAGONIST;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL HIPPOCAMPUS; FEMALE; HORMONE ACTION; LATERAL BRAIN VENTRICLE; MEMORY; MEMORY DISORDER; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; MEMORY DISORDERS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CHORIONIC GONADOTROPIN; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; HORMONE ANTAGONISTS; LUTEINIZING HORMONE; MEMORY DISORDERS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LH; SPATIAL MEMORY;

EID: 85008312466     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2016.11.007     Document Type: Article

References (87)

1. Apaja, P.M., Harju, K.T., Aatsinki, J.T., Petäjä-Repo, U.E., Rajaniemi, H.J., Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. J. Biol. Chem. 279 (2004), 1899–1906, 10.1074/jbc.M311395200.
2. Barron, A.M., Verdile, G., Taddei, K., Bates, K.A., Martins, R.N., Effect of chronic hCG administration on Alzheimer's-related cognition and Aβ accumulation in PS1KI mice. Endocrinology 151 (2010), 5380–5388, 10.1210/en.2009-1168.
3. Berry, A., Tomidokoro, Y., Ghiso, J., Thornton, J., Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-β levels in female rats. Horm. Behav. 54 (2008), 143–152, 10.1016/j.yhbeh.2008.02.006.
4. Blair, J.A., Bhatta, S., McGee, H., Casadesus, G., Luteinizing hormone: evidence for direct action in the CNS. Horm. Behav., 2015, 10.1016/j.yhbeh.2015.06.020.
5. Bove, R., Secor, E., Chibnik, L.B., Barnes, L.L., Schneider, J.A., Bennett, D.A., De Jager, P.L., Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82 (2014), 222–229, 10.1212/WNL.0000000000000033.
6. Bowen, R.L., Isley, J.P., Atkinson, R.L., An association of elevated serum gonadotropin concentrations and Alzheimer disease?. J. Neuroendocrinol. 12 (2000), 351–354 (doi:jne461 [pii).
7. Bowen, R.L., Perry, G., Xiong, C., Smith, M.A., Atwood, C.S., A clinical study of Lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose Lupron over 48 weeks. J. Alzheimers Dis., 2014, 10.3233/JAD-141626.
8. Bowen, R.L., Smith, M.A., Harris, P.L.R., Kubat, Z., Martins, R.N., Castellani, R.J., Perry, G., Atwood, C.S., Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J. Neurosci. Res. 70 (2002), 514–518, 10.1002/jnr.10452.
9. Bowen, R.L., Verdile, G., Liu, T., Parlow, A.F., Perry, G., Smith, M.A., Martins, R.N., Atwood, C.S., Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J. Biol. Chem. 279 (2004), 20539–20545, 10.1074/jbc.M311993200.
10. Bronstein, P.M., Open field behaviour of the rats as a function of age: cross sectional and longitudinal investigations. J. Comp. Physiol. Psychol., 80, 1972 (World Health Organization. 2015. Dementia –341).
11. Bryan, K.J., Mudd, J.C., Richardson, S.L., Chang, J., Lee, H.G., Zhu, X., Smith, M.A., Casadesus, G., Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits. J. Neurochem. 112 (2010), 870–881, 10.1111/j.1471-4159.2009.06502.x.
12. Carlson, M.C., Zandi, P.P., Plassman, B.L., Tschanz, J.T., Welsh-Bohmer, K.A., Steffens, D.C., Bastian, L.A., Mehta, K.M., Breitner, J.C., Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study. Neurology 57 (2001), 2210–2216.
13. Casadesus, G., Milliken, E.L., Webber, K.M., Bowen, R.L., Lei, Z., Rao, C.V., Perry, G., Keri, R.A., Smith, M.A., Increases in luteinizing hormone are associated with declines in cognitive performance. Mol. Cell. Endocrinol. 269 (2007), 107–111, 10.1016/j.mce.2006.06.013.
14. Casadesus, G., Webber, K.M., Atwood, C.S., Pappolla, M.A., Perry, G., Bowen, R.L., Smith, M.A., Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim. Biophys. Acta 1762 (2006), 447–452, 10.1016/j.bbadis.2006.01.008.
15. Charlton, H., Hypothalamic control of anterior pituitary function: a history. J. Neuroendocrinol. 20 (2008), 641–646, 10.1111/j.1365-2826.2008.01718.x.
16. Chen, H.C., Shimohigashi, Y., Dufau, M.L., Catt, K.J., Characterization and biological properties of chemically deglycosylated human chorionic gonadotropin. Role of carbohydrate moieties in adenylate cyclase activation. J. Biol. Chem. 257 (1983), 14446–14452.
17. Chu, C., Gao, G., Huang, W., A study on co-localization of FSH and its receptor in rat hippocampus. J. Mol. Histol. 39 (2008), 49–55, 10.1007/s10735-007-9125-2.
18. Coffey, C.E., Lucke, J.F., Saxton, J.A., Ratcliff, G., Unitas, L.J., Billig, B., Bryan, R.N., Sex differences in brain aging: a quantitative magnetic resonance imaging study. Arch. Neurol. 55 (1998), 169–179.
19. Cui, J., Shen, Y., Li, R., Estrogen synthesis and signaling in pathways during ageing: from periphery to brain. Trends Mol. Med. 19 (2013), 197–209.
20. Dufau, M.L., The luteinizing hormone receptor. Annu. Rev. Physiol. 60 (1998), 461–496.
21. Dunkel, L., Jia, X.C., Nishimori, K., Boime, I., Hsueh, A.J., Deglycosylated human chorionic gonadotropin (hCG) antagonizes hCG stimulation of 3′,5′-cyclic adenosine monophosphate accumulation through a noncompetitive interaction with recombinant human luteinizing hormone receptors. Endocrinology 132 (1993), 763–769.
22. Ennaceur, A., Meliani, K., Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests. Psychopharmacology 109 (1992), 321–330, 10.1007/BF02245880.
23. Ennaceur, A., Neave, N., Aggleton, J.P., Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp. Brain Res. 113 (1997), 509–519, 10.1007/PL00005603.
24. Fan, L., Zhao, Z., Orr, P., Chambers, C., Lewis, M., Frick, K., Estradiol-induced object memory consolidation in middle-aged female mice requires dorsal hippoxampal extracellular signal-regulated inase and phosphatidylinositol 3-kinase activation. J. Neurosci. 30 (2010), 4390–4400.
25. Farrag, A.F., Khedr, E.M., Abdel-Aleem, H., Rageh, T.A., Iwasa, T., Matsuzaki, T., Kinouchi, R., Gereltsetseg, G., Murakami, M., Munkhzaya, M., Altankhuu, T., Kuwahara, A., Yasui, T., Irahara, M., Effect of surgical menopause on cognitive functions. Dement. Geriatr. Cogn. Disord. 13 (2002), 193–198, 10.1159/000048652.
26. Fiddes, J.C., Talmadge, K., Structure, expression, and evolution of the genes for the human glycoprotein hormones. Recent Prog. Horm. Res. 40 (1984), 43–78.
27. Freeman, M.C., Dupke, K.C., Croteau, C.M., Extinction of the estrogen-induced daily signal for LH release in the rat: a role for the proestrous surge of progesterone. Endocrinology 99 (1976), 223–229, 10.1210/endo-99-1-223.
28. Gallo, R.V., Johnson, J.H., Kalra, S.P., Whitmoyer, D.I., Sawyer, C.H., Effects of luteinizing hormone on multiple-unit activity in the rat hippocampus. Neuroendocrinology 9 (1972), 149–157, 10.1159/000122046.
29. Gill, S., Sharpless, J.L., Rado, K., Hall, J.E., Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women. J. Clin. Endocrinol. Metab. 87 (2002), 2290–2296, 10.1210/jcem.87.5.8508.
30. Hebert, L.E., Weuve, J., Scherr, P.A., Evans, D.A., Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80 (2013), 1778–1783, 10.1212/WNL.0b013e31828726f5.
31. Heldt, S.A., Stanek, L., Chhatwal, J.P., Ressler, K.J., Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol. Psychiatry 12 (2007), 656–670, 10.1038/sj.mp.4001957.
32. Hogervorst, E., Bandelow, S., Combrinck, M., Smith, A.D., Low free testosterone is an independent risk factor for Alzheimer's disease. Exp. Gerontol. 39 (2004), 1633–1639, 10.1016/j.exger.2004.06.019.
33. Hyde, Z., Flicker, L., Almeida, O.P., McCaul, K.A., Jamrozik, K., Hankey, G.J., Chubb, S.A.P., Yeap, B.B., Higher luteinizing hormone is associated with poor memory recall: the health in men study. J. Alzheimers Dis. 19 (2010), 943–951, 10.3233/JAD-2010-1342.
34. Jennes, L., Conn, P.M., Gonadotropin-releasing hormone and its receptors in rat brain. Front. Neuroendocrinol. 15 (1994), 51–77, 10.1006/frne.1994.1003.
35. Jorm, a.F., Korten, a.E., Henderson, a.S., The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76 (1987), 465–479, 10.1111/j.1600-0447.1987.tb02906.x.
36. Kalyan, N.K., Bahl, O.P., Role of carbohydrate in human chorionic gonadotropin. Effect of deglycosylation on the subunit interaction and on its in vitro and in vivo biological properties. J. Biol. Chem. 258 (1983), 67–74.
37. Karsch, F.J., Dierschke, D.J., Knobil, E., Sexual differentiation of pituitary function: apparent difference between primates and rodents. Science 179:80 (1973), 484–486, 10.1126/science.179.4072.484.
38. Kato, K., Sairam, M.R., Manjunath, P., Inhibition of implantation and termination of pregnancy in the rat by a human chorionic gonadotropin antagonist. Endocrinology 113 (1983), 195–199.
39. Kawakami, M., Sawyer, C.H., Induction of behavioral and electroencephalographic changes in the rabbit by hormone administration or brain stimulation. Horm. Behav. 65 (1959), 631–643.
40. Kessels, R.P.C., de Haan, E.H.F., Kappelle, L.J., Postma, A., Varieties of human spatial memory: a meta-analysis on the effects of hippocampal lesions. Brain Res. Rev. 35 (2001), 295–303, 10.1016/S0165-0173(01)00058-3.
41. Knowles, S.F., Topics in neuroendocrinology, progress in brain research. Prog. Brain Res., 1972, 10.1016/S0079-6123(08)64278-8 (Elsevier).
42. Kovacs, M., Schally, A.V., Csernus, B., Rekasi, Z., Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 1829–1834, 10.1073/pnas.031582398.
43. Kunal, S., Killivalavan, A., Medhamurthy, R., Involvement of Src family of kinases and cAMP phosphodiesterase in the luteinizing hormone/chorionic gonadotropin receptor-mediated signaling in the corpus luteum of monkey. Reprod. Biol. Endocrinol., 10, 2010, 25, 10.1186/1477-7827-10-25.
44. Legan, S.J., Coon, G.A., Karsch, F.J., Role of estrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology 96 (1975), 50–56, 10.1210/endo-96-1-50.
45. Lei, Z.M., Rao, C.V., Kornyei, J.L., Licht, P., Hiatt, E.S., Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 132 (1993), 5322–5329.
46. Lenton, E.A., Sexton, L., Lee, S., Cooke, I.D., Progressive changes in LH and FSH and LH: FSH ratio in women throughout reproductive life. Maturitas 10 (1988), 35–43, 10.1016/0378-5122(88)90129-6.
47. Lin, J., Li, X., Yuan, F., Lin, L., Cook, C.L., Rao, C.V., Lei, Z., Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 69 (2010), 253–261, 10.1097/NEN.0b013e3181d072cf.
48. Lukacs, H., Hiatt, E.S., Lei, Z.M., Rao, C.V., Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm. Behav. 29 (1995), 42–58, 10.1006/hbeh.1995.1004.
49. Maguschak, K.A., Ressler, K.J., Beta-catenin is required for memory consolidation. Nat. Neurosci. 11 (2008), 1319–1326, 10.1038/nn.2198.
50. Mann, D.M.A., The pathological association between down syndrome and Alzheimer disease. Mech. Ageing Dev. 43 (1988), 99–136, 10.1016/0047-6374(88)90041-3.
51. McGonigal, G., Thomas, B., McQuade, C., Starr, J.M., MacLennan, W.J., Whalley, L.J., Epidemiology of Alzheimer's presenile dementia in Scotland, 1974–88. BMJ 306 (1993), 680–683, 10.1136/bmj.306.6879.680.
52. Mumby, D.G., Gaskin, S., Glenn, M.J., Schramek, T.E., Lehmann, H., Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn. Mem. 9 (2002), 49–57, 10.1101/lm.41302.
53. Nuruddin, S., Syverstad, G.H., Lillehaug, S., Leergaard, T.B., Nilsson, L.N., Ropstad, E., Krogenæs, A., Haraldsen, I.R., Torp, R., Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic mice. PLoS One, 9, 2014, e103607.
54. Oliver, C., Holland, A.J., Down's syndrome and Alzheimer's disease: a review. Psychol. Med. 16 (1986), 307–322, 10.1017/S0033291700009120.
55. Oliver, C., Mical, R.S., Porter, J.C., Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk. Endocrinology 101 (1977), 598–604, 10.1210/endo-101-2-598.
56. Palm, R., Chang, J., Blair, J., Garcia-Mesa, Y., Lee, H.-G., Castellani, R.J., Smith, M.A., Zhu, X., Casadesus, G., Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice. J. Neurochem. 130 (2014), 115–125, 10.1111/jnc.12706.
57. Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates Sixth Edition. vol. 170, 2006, Acad. Press, 547612, 10.1016/0143-4179(83)90049-5.
58. Phillips, H.S., Hains, J.M., Armanini, M., Laramee, G.R., Johnson, S.A., Winslow, J.W., BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7 (1991), 695–702, 10.1016/0896-6273(91)90273-3.
59. Phillips, S.M., Sherwin, B.B., Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17 (1992), 485–495, 10.1016/0306-4530(92)90007-T.
60. Pidoux, G., Gerbaud, P., Tsatsaris, V., Marpeau, O., Ferreira, F., Meduri, G., Guibourdenche, J., Badet, J., Evain-Brion, D., Frendo, J.-L., Biochemical characterization and modulation of LH/CG-receptor during human trophoblast differentiation. J. Cell. Physiol. 212 (2007), 26–35.
61. Pothuizen, H.H.J., Zhang, W.N., Jongen-Rêlo, A.L., Feldon, J., Yee, B.K., Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur. J. Neurosci. 19 (2004), 705–712, 10.1111/j.0953-816X.2004.03170.x.
62. Prange-Kiel, J., Jarry, H., Schoen, M., Kohlmann, P., Lohse, C., Zhou, L., Rune, G.M., Gonadotropin-releasing hormone regulates spine density via its regulatory role in hippocampal estrogen synthesis. J. Cell Biol. 180 (2008), 417–426, 10.1083/jcb.200707043.
63. Rannevik, G., Jeppsson, S., Johnell, O., Bjerre, B., Laurell-Borulf, Y., Svanberg, L., A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21 (1995), 103–113, 10.1016/0378-5122(94)00869-9.
64. Rao, C.V., Differential properties of human chorionic gonadotrophin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea. Acta Endocrinol. 90 (1979), 696–710, 10.1530/acta.0.0900696.
65. Richardson, M.C., Masson, G.M., Sairam, M.R., Inhibitory action of chemically deglycosylated human chorionic gonadotrophin on hormone-induced steroid production by dispersed cells from human corpus luteum. J. Endocrinol. 101 (1984), 327–332, 10.1677/joe.0.1010327.
66. Rocca, W.a., Grossardt, B.R., Shuster, L.T., Stewart, E.a., Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener. Dis. 10 (2012), 175–178, 10.1159/000334764.
67. Rodrigues, M.A., Verdile, G., Foster, J.K., Hogervorst, E., Joesbury, K., Dhaliwal, S., Corder, E.H., Laws, S.M., Hone, E., Prince, R., Devine, A., Mehta, P., Beilby, J., Atwood, C.S., Martins, R.N., Gonadotropins and cognition in older women. J. Alzheimers Dis. 13 (2008), 267–274.
68. Rushworth, A.G., Orr, A.H., Bagshawe, K.D., The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system. Br. J. Cancer 22 (1968), 253–257.
69. Sairam, M.R., Manjunath, P., Hormonal antagonistic properties of chemically deglycosylated human choriogonadotropin. J. Biol. Chem. 258 (1983), 445–449.
70. Schang, A.-L., Ngô-Muller, V., Bleux, C., Granger, A., Chenut, M.-C., Loudes, C., Magre, S., Counis, R., Cohen-Tannoudji, J., Laverrière, J.-N., GnRH receptor gene expression in the developing rat hippocampus: transcriptional regulation and potential roles in neuronal plasticity. Endocrinology 152 (2011), 568–580, 10.1210/en.2010-0840.
71. Short, R.A., Bowen, R.L., O'Brien, P.C., Graff-Radford, N.R., Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin. Proc. 76 (2001), 906–909.
72. Smith, Y.R., Bowen, L., Love, T.M., Berent-Spillson, A., Frey, K.A., Persad, C.C., Reame, N.K., Koeppe, R.A., Zubieta, J.-K., Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity. J. Clin. Endocrinol. Metab. 96 (2011), E1761–E1770, 10.1210/jc.2011-0351.
73. Spratt, D.I., O'Dea, L.S., Schoenfeld, D., Butler, J., Rao, P.N., Crowley, W.F., Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am. J. Phys. 254 (1988), E658–E666.
74. Telegdy, G., Tanaka, M., Schally, A.V., Effects of the LHRH antagonist Cetrorelix on the brain function in mice. Neuropeptides 43 (2009), 229–234, 10.1016/j.npep.2009.03.001.
75. Toledo, E.M., Inestrosa, N.C., Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Mol. Psychiatry, 15(272–85), 2010, 228, 10.1038/mp.2009.72.
76. Van Loenen, H.J., van Gelderen-Boele, S., Flinterman, J.F., Merz, W.E., Rommerts, F.F., The relative importance of the oligosaccharide units in human chorionic gonadotropin (CG) for LH/CG receptor activation in rat Leydig cells and mouse Leydig tumor cells. J. Endocrinol. 147 (1995), 367–375, 10.1677/joe.0.1470367.
77. Verdile, G., Laws, S.M., Henley, D., Ames, D., Bush, A.I., Ellis, K.A., Faux, N.G., Gupta, V.B., Li, Q.-X., Masters, C.L., Pike, K.E., Rowe, C.C., Szoeke, C., Taddei, K., Villemagne, V.L., Martins, R.N., Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. Mol. Psychiatry 19 (2014), 69–75, 10.1038/mp.2012.147.
78. Wahjoepramono, E.J., Wijaya, L.K., Taddei, K., Bates, K.A., Howard, M., Martins, G., Deruyck, K., Matthews, P.M., Verdile, G., Martins, R.N., Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels. Neuroendocrinology 94 (2011), 313–322, 10.1159/000330812.
79. Weinbauer, G.F., Nieschlag, E., Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis). Andrologia 25 (1993), 141–147, 10.1111/j.1439-0272.1993.tb02698.x.
80. Wharton, W., Baker, L.D., Gleason, C.E., Dowling, M., Barnet, J.H., Johnson, S., Carlsson, C., Craft, S., Asthana, S., Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. J. Alzheimers Dis. 26 (2011), 495–505, 10.3233/JAD-2011-110341.
81. Wiacek, M., Hagner, W., Zubrzycki, I.Z., Measures of menopause driven differences in levels of blood lipids, follicle-stimulating hormone, and luteinizing hormone in women aged 35 to 60 years: national health and nutrition examination survey III and national health and nutrition examination Surv. Menopause 18 (2011), 60–66, 10.1097/gme.0b013e3181e7060b.
82. Wilson, A.C., Meethal, S.V., Bowen, R.L., Atwood, C.S., Leuprolide acetate: a drug of diverse clinical applications. Expert Opin. Investig. Drugs 16 (2007), 1851–1863, 10.1517/13543784.16.11.1851.
83. Wise, P.M., Ratner, A., Effect of ovariectomy on plasma LH, FSH, estradiol, and progesterone and medial basal hypothalamic LHRH concentrations old and young rats. Neuroendocrinology 30 (1980), 15–19.
84. World Health Organization, Dementia Fact Sheet. 2015 (www.who.int/mediacentre/factsheets/fs362/en/).
85. Yen, S., Llerena, O., Little, B., Pearson, O., Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J. Clin. Endocrinol. Metab. 28 (1968), 1763–1767.
86. Ziegler, S.G., Thornton, J.E., Low luteinizing hormone enhances spatial memory and has protective effects on memory loss in rats. Horm. Behav. 58 (2010), 705–713, 10.1016/j.yhbeh.2010.07.002.
87. Zhang, W., Lei, Z.M., Rao, C.V., Immortalized hippocampal cells contain functional luteinizing hormone/human chorionic gonadotropin receptors. Life Sci. 65 (1999), 2083–2098, 10.1016/S0024-3205(99)00474-9.